INC.

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

by

SAN DIEGO, May 22, 2023 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on May 20, 2023, the Human Capital Management Committee of Avidity’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 36,900 shares of … Read more

Endotronix erweitert positive Ergebnisse mit der Veröffentlichung von 12-Monats-Daten aus der Studie SIRONA 2 zum Fernmanagement von Herzinsuffizienz mit dem Cordella Pulmonal Artery Sensor Middle East – English USA – English USA – español USA – English Brazil – Português USA – español Latin America – español

by

Die Studie erfüllte die sekundären Studienendpunkte, und die langfristige Verwendung des Sensors war mit signifikanten Verbesserungen der Kennwerte für die Lebensqualität der Patienten sowie niedrigen Ereignisraten bezüglich Hospitalisierung und Todesfällen im Zusammenhang mit Herzinsuffizienz verbunden  LISLE, Illinois, 22. Mai 2023 /PRNewswire/ — Endotronix, Inc., ein Unternehmen für digitale Gesundheits- und Medizintechnik, das sich der Verbesserung der … Read more

Corvia Medical publica los resultados que confirman el beneficio para pacientes con insuficiencia cardiaca

by

– Corvia Medical publica los resultados del ensayo clínico de dos años que confirman el beneficio sostenido y la seguridad de su derivación auricular en pacientes con insuficiencia cardiaca El primer ensayo controlado aleatorizado de fase III de terapia de derivación auricular muestra un beneficio continuo TEWKSBURY, Mass., 22 de mayo de 2023 /PRNewswire/ — … Read more

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

by

SAN DIEGO, May 22, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received Ethics Review Board (ERB) approval from the Maulana Azad Medical College (MAMC), for a second site for its ongoing … Read more

Pharmaceutical Filtration Market to be Worth $21.96 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 22, 2023 /PRNewswire/ — The global pharmaceutical filtration market size is estimated to reach USD 21.96 billion by 2030, registering a CAGR of 8.03% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.03% from 2023 to … Read more

IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid Tumors

by

IDE397 (MAT2A) and AMG 193 (PRMT5) combination being evaluated in an Amgen-sponsored Phase 1/2 clinical trial in MTAP-deletion solid tumors Potential first-in-class synthetic lethality combination targets mechanistically complementary nodes of the MTAP methylation pathway – MAT2A and PRMT5 Compelling preclinical anti-tumor efficacy presented at AACR 2023 with durable CRs for IDE397 / AMG 193 combination, … Read more

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

by

FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEWKSBURY, Mass., May 22, 2023 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt … Read more

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

by

CANTON, Conn., May 22, 2023 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023. “I’m pleased to announce that Kelyniam has expanded our licensing agreement with Bioplate to allow the Company to sell Osteopore products in select markets in the U.S.  Kelyniam will have the opportunity to sell these unique, … Read more

DocuSign Announces Timing of First Quarter Fiscal 2024 Earnings Conference Call

by

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — DocuSign (Nasdaq: DOCU) today announced that its first quarter fiscal 2024 results will be released on Thursday, June 8, 2023, after the close of the market. The company will host a conference call at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will … Read more

Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab

by

Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will  introduce navify® digital solutions that help laboratories address their needs for digital infrastructure, operational excellence and medical insights. Attendees can experience an integrated lab that goes beyond simply connecting individual technologies to demonstrate … Read more